te Booy M P, Riethorst W, Faber A, Over J, König B W
Dept. of Development and Quality Assurance, Netherlands Red Cross Blood Transfusion Service, Amsterdam.
Thromb Haemost. 1989 Apr 25;61(2):234-7.
For the purification of coagulation factor VIII, (1,1'-carbonyl-diimidazole [CDI]-activated) Sepharose CL-4B was functionalized with two aminoalkyl and four aminoalkyl-carbamylalkyl ligand-spacer combinations. The affinity matrices were contacted with human plasma. All affinity matrices showed complete adsorption of factor VIII (greater than 90%) and three aminoalkyl-carbamylalkyl Sepharoses gave factor-VIII recoveries of 50-65% and a factor-VIII preparation with a specific activity of 1-2 U factor VIII/mg of protein. Furthermore, no fibrinogen, immunoglobulin G and albumin could be detected in the isolated factor VIII. Optimal results were obtained using the di-methyl-aminopropyl-carbamyl-pentyl-Sepharose affinity matrix.
为了纯化凝血因子VIII,用两种氨基烷基和四种氨基烷基-氨基甲酰烷基配体-间隔基组合对(1,1'-羰基-二咪唑[CDI]活化的)琼脂糖凝胶CL-4B进行功能化。使亲和基质与人血浆接触。所有亲和基质均显示出对因子VIII的完全吸附(大于90%),三种氨基烷基-氨基甲酰烷基琼脂糖凝胶的因子VIII回收率为50-65%,且所制备的因子VIII的比活性为1-2 U因子VIII/毫克蛋白质。此外,在分离出的因子VIII中未检测到纤维蛋白原、免疫球蛋白G和白蛋白。使用二甲基氨基丙基-氨基甲酰戊基-琼脂糖凝胶亲和基质可获得最佳结果。